Clinical Trials
2 trialsNCT04831944 2022-08-26
To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.
Incyte Corporation
Phase 1 Completed
NCT04831996 2022-08-17
To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Renal Function and Renal Impairment.
Incyte Corporation
Phase 1 Completed